TCR-based Therapies Virtual Summit

Tuesday, October 20, 2020 to Friday, December 18, 2020

The only dedicated end-to-end, industry led TCR therapy summit is a unique opportunity to delve into the details of TCR development. This technical meeting is a rare opportunity to learn from 20+ industry experts from Ziopharm, Immatics US, TScan Therapeutics and many more. Gain insights on their various approaches and be the first to hear cutting-edge data from this fast-paced industry.

A 23.1% growth rate since 2009 spells progress in the TCR-Based therapies space. This dedicated meeting brings you the industry leaders pushing the bounds of T Cell therapies. With a building number of Phase 1 and Phase 2 trials on the horizon, stay ahead of this booming field at the TCR-based therapies summit.

Covering the most exciting developments and promising clinical data, the TCR-based Therapies Summit will propel your research ahead in 2020 with optimized target identification, supercharged T-cell modifications and insights to the future of manufacturing. For leaders in the TCR space, this is not a meeting to be missed!

https://tcr-therapies-summit.com/

Contact:
info@hansonwade.com
+1 617 455 4188

Event Information

Organiser
Hanson Wade
Location
Virtual
00000 Digital
Switzerland
UICC Member
No
This event is under the auspices of UICC
No
Last update: 
Tuesday 29 September 2020
Share